| Autor: |
Podzolkov VI; Sechenov First Moscow State Medical University (Sechenov University)., Vetluzhskaya MV; Sechenov First Moscow State Medical University (Sechenov University)., Medvedev ID; Sechenov First Moscow State Medical University (Sechenov University)., Abramova AA; Sechenov First Moscow State Medical University (Sechenov University)., Kislenko GA; Sechenov First Moscow State Medical University (Sechenov University). |
| Jazyk: |
ruština |
| Zdroj: |
Terapevticheskii arkhiv [Ter Arkh] 2024 Jul 30; Vol. 96 (7), pp. 706-712. Date of Electronic Publication: 2024 Jul 30. |
| DOI: |
10.26442/00403660.2024.07.202785 |
| Abstrakt: |
New coronavirus infection may lead to long-term consequences, particularly to post-COVID syndrome, one of the most common manifestations of which is dyspnea. Post-COVID-19 shortness of breath may persist from one to several months and even years that results in low quality of life of patients. The review highlights possible risk factors and causes of dyspnea in post-COVID period such as lung damage, cardiovascular pathology, hyperventilation syndrome, dysfunction of the autonomic nervous system, detraining, anemia, etc. The authors present data about COVID-19-associated causes of dyspnea and severity of acute COVID-19. The review emphasizes the importance of a multidisciplinary approach to the diagnosis and treatment of patients with shortness of breath in post-COVID-19 period. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
